亞輝龍(688575.SH):一季度淨利潤預增1094.75%-1227.50%
格隆匯4月14日丨亞輝龍(688575.SH)公佈2022年第一季度業績預增公吿,經財務部門初步測算,預計2022年第一季度實現歸屬於母公司所有者的淨利潤為4.5億元至5億元,與上年同期相比,增加4.12億元至4.62億元,同比增加1094.75%至1227.50%。
歸屬於母公司所有者的扣除非經常性損益的淨利潤為4.48億元至4.98億元,與上年同期相比,增加4.13億元至4.63億元,同比增加1189.00%至1332.86%。
業績變化的主要原因:自2021年年底至報吿期末,公司新型冠狀病毒抗原檢測試劑盒(膠體金法)先後取得歐盟CE認證、日本PMDA認證指定供應、國家藥監局醫療器械註冊證等准入認證,相關產品在歐洲、日本、中國(包括香港地區)等市場均實現了銷售,該產品的銷售收入增長,導致公司2022年第一季度業績較去年同期實現較大幅度增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.